Histogen (HSTO, $0.21) was a top loser this month, diving to $0.21 per share. Of the 903 stocks analyzed in the Biotechnology Industry throughout this month, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend.
a company, which engages in the development of patented, innovative technologies that replace and regenerate tissues in the body for the aesthetic and therapeutic markets